oral semaglutide novo Novo's reduced risk of multiple diseases Novo Nordisk's oral diabetes drug

Microdosing GLP-1s began emerging as a trend after Wegovy, an Ozempic competitor, was approved by the FDA for obesity in 2021

Lisa DiFrancesco is a female board-certified plastic surgeon based in Atlanta, GA

Building A Sensible Combo Approach Any thoughtful approach to this pairing borrows the same principle that ran through every successful trial, which is start low and climb slowly

You have Stokes-Adams syndrome, Wolff-Parkinson-White syndrome, or cardiac block without a pacemaker

Stay Hydrated Maintaining good hydration can support digestion and help food move through the digestive system more comfortably while taking GLP-1 medications